新药审批华东医药 注射用HDM201212月15日，华东医药子公司中美华东自主研发的ADC创新药注射用HDM2012的胃癌和胃食管交界癌、胰腺癌两项适应症获得美国食品药品监督管理局（FDA）孤儿药资格认定。海思科HSK45019片 HSK50042片 注射用HSK5571812月15日，HSK45019片、HSK50042片获批临床，适应症分别为拟开发治疗炎症性肠病（包括溃疡性结肠炎和克罗恩病）和...
Source Link新药审批华东医药 注射用HDM201212月15日，华东医药子公司中美华东自主研发的ADC创新药注射用HDM2012的胃癌和胃食管交界癌、胰腺癌两项适应症获得美国食品药品监督管理局（FDA）孤儿药资格认定。海思科HSK45019片 HSK50042片 注射用HSK5571812月15日，HSK45019片、HSK50042片获批临床，适应症分别为拟开发治疗炎症性肠病（包括溃疡性结肠炎和克罗恩病）和...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.